Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells
British Journal of Cancer, 04/27/2012Wang J et al.
On the basis of the expected impact of these two drugs on OCT–1 activity (OA), ibuprofen should be avoided in combination with imatinib. Further studies are warranted regarding the potential benefit of diclofenac to improve OA in a clinical setting.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.